Societe de Therapeutique Marocaine S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was MAD 1,150.23 million compared to MAD 972.67 million a year ago. Net income was MAD 158.28 million compared to MAD 130.88 million a year ago.

Basic earnings per share from continuing operations was MAD 22 compared to MAD 18 a year ago. Diluted earnings per share from continuing operations was MAD 22 compared to MAD 18 a year ago.